ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
종양학 기기 시장 규모는 최근 빠르게 확대하고 있습니다. 2025년 1,777억 2,000만 달러에서 2026년에는 2,101억 5,000만 달러로, CAGR 18.2%로 성장할 것으로 예상됩니다. 지난 수년간의 성장 요인으로는 전 세계 암 발생률 증가, 병원 내 종양학과 부서의 확대, 조기 진단 기술에 대한 수요 증가, 첨단 영상 진단 시스템의 보급, 암 검진 프로그램에 대한 인식 개선 등을 꼽을 수 있습니다.
종양학 기기 시장 규모는 향후 몇 년간 급속한 성장이 전망됩니다. 2030년에는 3,972억 7,000만 달러에 달하고, CAGR은 17.3%가 될 전망입니다. 예측 기간 동안의 성장에는 맞춤형 암 치료 기기 도입 증가, 종양학 인프라 투자 확대, 외래 암 치료 시설 확충, AI 기반 진단 도구 사용 확대, 정밀 종양학 솔루션에 대한 집중도 강화 등이 요인으로 작용할 것으로 보입니다. 예측 기간의 주요 동향으로는 첨단 암 진단기기 도입 증가, 영상유도 종양학 치료의 이용 확대, 최소침습적 암 치료 도구의 통합 촉진, 정밀 방사선 치료 장비의 확대, 조기 암 발견에 대한 집중도 강화 등을 들 수 있습니다.
화학요법에 대한 수요 증가는 향후 몇 년 동안 종양학 기기 시장의 성장을 견인할 것으로 예상됩니다. 화학요법은 강력한 약물을 사용하여 빠르게 분열하는 세포를 제거하여 종양의 성장과 확산을 늦추거나 막는 암 치료법입니다. 화학요법에 대한 수요 증가는 전 세계 암 발생률의 증가에 기인하며, 암 진단 건수 증가에 따라 다양한 종류와 단계의 암에 대응할 수 있는 효과적이고 광범위하게 사용 가능한 치료법에 대한 필요성이 증가하고 있기 때문입니다. 종양학 기기는 보다 안전하고 정확한 약물 투여 및 모니터링을 가능하게함으로써 화학요법을 지원하고, 치료 효과와 환자 결과를 개선합니다. 예를 들어, 미국 연방 암 연구기관인 미국 국립암연구소(NCI)에 따르면, 2025년 1월 기준 미국 내 신규 암 발생 건수는 2023년 196만 건에서 증가하여 204만 건에 달할 것으로 예측하고 있습니다. 이는 화학요법 투여 시스템에 대한 수요 증가를 뒷받침합니다. 따라서 화학요법에 대한 수요 증가가 종양학 기기 시장의 성장에 기여하고 있습니다.
종양학 기기 시장에서 활동하는 주요 기업들은 치료 정확도, 환자 안전, 임상 워크플로우 효율성 향상을 위한 첨단 정밀 지향적 솔루션 개발에 주력하고 있습니다. 이러한 혁신은 최소침습적 기술, 향상된 시각화, 실시간 치료 최적화에 초점을 맞춰 다양한 암종에서 좋은 치료 결과를 얻을 수 있도록 돕습니다. 예를 들어, 2025년 4월 독일에 본사를 둔 의료 기술 기업 자이스는 신경 종양학 및 유방암 수술에서 표적 방사선 조사를 목적으로 하는 차세대 로봇 보조 수술 중 방사선 치료(IORT) 플랫폼 'INTRABEAM 700' 시스템에 대해 FDA 510(k) 승인을 획득했습니다. 이 시스템은 정확도 향상, 인체공학적 최적화, 수술 워크플로우에 대한 통합성 강화를 실현하여 임상의가 수술 중 국소 방사선 조사와 동시에 주변 정상 조직에 대한 피폭을 줄일 수 있게 해줍니다. 첨단 영상 진단 기술, 로봇 공학, 치료 계획 기능을 통합한 INTRABEAM 700은 치료 정확도를 높이고, 임상적 판단을 신속하게 내릴 수 있도록 하며, 기술적으로 진보된 환자 중심의 종양 치료로의 전환을 돕습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장에서 세계의 총 잠재 시장 규모(TAM)
제9장 시장 세분화
제10장 지역별, 국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 방글라데시 시장
제19장 태국 시장
제20장 베트남 시장
제21장 말레이시아 시장
제22장 싱가포르 시장
제23장 필리핀 시장
제24장 홍콩 시장
제25장 뉴질랜드 시장
제26장 대만 시장
제27장 동남아시아 시장
제28장 서유럽 시장
제29장 영국 시장
제30장 독일 시장
제31장 프랑스 시장
제32장 이탈리아 시장
제33장 스페인 시장
제34장 오스트리아 시장
제35장 벨기에 시장
제36장 덴마크 시장
제37장 핀란드 시장
제38장 아일랜드 시장
제39장 네덜란드 시장
제40장 노르웨이 시장
제41장 포르투갈 시장
제42장 스웨덴 시장
제42장 스위스 시장
제43장 동유럽 시장
제44장 러시아 시장
제45장 체코 시장
제46장 폴란드 시장
제47장 루마니아 시장
제48장 우크라이나 시장
제49장 북미 시장
제50장 미국 시장
제51장 캐나다 시장
제52장 멕시코 시장
제53장 남미 시장
제54장 브라질 시장
제55장 칠레 시장
제56장 아르헨티나 시장
제57장 콜롬비아 시장
제58장 페루 시장
제59장 중동 시장
제60장 사우디아라비아 시장
제61장 이스라엘 시장
제62장 이란 시장
제63장 튀르키예 시장
제64장 아랍에미리트 시장
제65장 아프리카 시장
제66장 이집트 시장
제67장 나이지리아 시장
제68장 남아프리카공화국 시장
제69장 시장 규제 상황과 투자 환경
제70장 경쟁 구도와 기업 개요
제71장 기타 주요 기업과 혁신적 기업
제72장 세계의 시장 경쟁 벤치마킹과 대시보드
제73장 주요 인수합병
제74장 시장 잠재력이 높은 국가, 부문, 전략
제75장 부록
KSM
영문 목차
영문목차
Oncology devices are specialized medical devices utilized for the diagnosis, management, and treatment of cancer.
The primary device categories within the field of oncology devices include brachytherapy devices and endoscopic devices. Endoscopic devices serve a critical role in the diagnosis, management, and treatment of cancer by allowing healthcare professionals to visually inspect the internal body cavities and organs for abnormalities. These devices find applications in various cancer therapies, including chemotherapy, hormone therapy, biotherapy/immunotherapy, and radiation therapy. They are employed by a range of end-users, including hospitals, cancer research institutes, and other medical facilities dedicated to cancer care and research.
Tariffs are influencing the oncology devices market by increasing costs of imported imaging systems, radiation therapy equipment, endoscopic devices, precision components, and electronic subsystems used in cancer diagnosis and treatment. Hospitals and cancer centers in North America and Europe are most affected due to reliance on imported high-end oncology equipment, while Asia-Pacific faces pricing pressure on equipment manufacturing and exports. These tariffs are increasing capital investment requirements and slowing technology upgrades. However, they are also encouraging domestic manufacturing, localized assembly of oncology systems, and innovation in cost-efficient cancer care technologies.
The oncology devices market research report is one of a series of new reports from The Business Research Company that provides oncology devices market statistics, including oncology devices industry global market size, regional shares, competitors with a oncology devices market share, detailed oncology devices market segments, market trends and opportunities, and any further data you may need to thrive in the oncology devices industry. This oncology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The oncology devices market size has grown rapidly in recent years. It will grow from $177.72 billion in 2025 to $210.15 billion in 2026 at a compound annual growth rate (CAGR) of 18.2%. The growth in the historic period can be attributed to increasing global cancer incidence rates, expansion of hospital oncology departments, growing demand for early diagnosis technologies, availability of advanced imaging systems, rising awareness of cancer screening programs.
The oncology devices market size is expected to see rapid growth in the next few years. It will grow to $397.27 billion in 2030 at a compound annual growth rate (CAGR) of 17.3%. The growth in the forecast period can be attributed to increasing adoption of personalized cancer treatment devices, rising investments in oncology infrastructure, expansion of outpatient cancer treatment facilities, growing use of AI-driven diagnostic tools, increasing focus on precision oncology solutions. Major trends in the forecast period include increasing adoption of advanced cancer diagnostic devices, rising use of image-guided oncology therapies, growing integration of minimally invasive cancer treatment tools, expansion of precision radiation therapy equipment, enhanced focus on early cancer detection.
The growing demand for chemotherapy is anticipated to drive the expansion of the oncology devices market in the coming years. Chemotherapy is a cancer treatment that involves the use of potent drugs to eliminate rapidly dividing cells, thereby slowing or halting tumor growth and spread. The rising demand for chemotherapy is driven by the increasing global incidence of cancer, as a higher number of diagnosed cases leads to greater need for effective and widely available treatments capable of addressing various cancer types and stages. Oncology devices support chemotherapy by facilitating safer and more accurate drug delivery and monitoring, which improves treatment efficacy and patient outcomes. For example, in January 2025, according to the U.S. National Cancer Institute, a U.S.-based federal cancer research agency, new cancer cases in the United States are projected to reach 2.04 million, up from 1.96 million in 2023, underscoring the growing need for chemotherapy administration systems. Therefore, the rising demand for chemotherapy is contributing to the growth of the oncology devices market.
Major companies operating in the oncology devices market are concentrating on the development of advanced, precision-oriented solutions to enhance treatment accuracy, patient safety, and clinical workflow efficiency. These innovations focus on minimally invasive technologies, improved visualization, and real-time therapy optimization to support better outcomes across a wide range of cancer types. For example, in April 2025, ZEISS, a Germany-based medical technology company, obtained FDA 510(k) clearance for its INTRABEAM 700 system, a next-generation robotic-assisted intraoperative radiotherapy (IORT) platform intended for targeted radiation delivery in neuro-oncology and breast cancer procedures. The system provides increased precision, optimized ergonomics, and improved integration into surgical workflows, allowing clinicians to deliver localized radiation during surgery while reducing exposure to surrounding healthy tissue. By integrating advanced imaging, robotics, and treatment-planning capabilities, the INTRABEAM 700 improves therapeutic accuracy, enables faster clinical decision-making, and supports the industry's transition toward technologically sophisticated, patient-focused oncology care.
In March 2024, Halma PLC, a UK-based company specializing in life-saving technologies that prevent injuries, save lives, and protect people and assets, acquired Rovers Medical Devices B.V. for $93.5 million. This acquisition is intended to expand Halma PLC's market presence in women's health and enhance its capabilities in cancer diagnostics. Rovers Medical Devices B.V. is a Netherlands-based company focused on designing, developing, and manufacturing medical devices for cancer screening.
Major companies operating in the oncology devices market are Eckert & Ziegler BEBIG GmbH, Oncura Inc., GE Healthcare, Medtronic plc, Varian Medical Systems Inc., Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer, RaySearch Laboratories, Mevion Medical Systems, Vision RT, IsoRay, RefleXion Medical, Alpha Tau Medical, Nanobiotix, Mirada Medical Ltd., Navidea Biopharmaceuticals Inc.
North America was the largest region in the oncology devices market in 2025. Asia-Pacific was the second-largest region in the oncology devices market report. The regions covered in the oncology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the oncology devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The oncology devices market consists of sales of brachytherapy devices and endoscopic devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Oncology Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses oncology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for oncology devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The oncology devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Device Type: Brachytherapy Devices; Endoscopic Devices
2) By Therapy: Chemotherapy; Hormone Therapy; Biotherapy/Immunotherapy; Radition Therapy
3) By End User: Hospitals; Cancer Research Institutes; Other End Users
Subsegments:
1) By Brachytherapy Devices: Afterloaders (High-Dose Rate (HDR) And Low-Dose Rate (LDR)); Applicators; Seeds; Accessories
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Increasing Adoption Of Advanced Cancer Diagnostic Devices
4.2.2 Rising Use Of Image-Guided Oncology Therapies
4.2.3 Growing Integration Of Minimally Invasive Cancer Treatment Tools
4.2.4 Expansion Of Precision Radiation Therapy Equipment
4.2.5 Enhanced Focus On Early Cancer Detection
5. Oncology Devices Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Cancer Treatment Centers
5.3 Oncology Clinics
5.4 Cancer Research Institutes
5.5 Diagnostic Imaging Centers
6. Oncology Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Oncology Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Oncology Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Oncology Devices Market Size, Comparisons And Growth Rate Analysis
7.3. Global Oncology Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Oncology Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Oncology Devices Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Oncology Devices Market Segmentation
9.1. Global Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Brachytherapy Devices, Endoscopic Devices
9.2. Global Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.3. Global Oncology Devices Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Cancer Research Institutes, Other End Users
9.4. Global Oncology Devices Market, Sub-Segmentation Of Brachytherapy Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Oncology Devices Market
12.1. China Oncology Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Oncology Devices Market
13.1. India Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Oncology Devices Market
14.1. Japan Oncology Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Oncology Devices Market
15.1. Australia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Oncology Devices Market
16.1. Indonesia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Oncology Devices Market
17.1. South Korea Oncology Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Bangladesh Oncology Devices Market
18.1. Bangladesh Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. Thailand Oncology Devices Market
19.1. Thailand Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Vietnam Oncology Devices Market
20.1. Vietnam Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. Malaysia Oncology Devices Market
21.1. Malaysia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Singapore Oncology Devices Market
22.1. Singapore Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. Philippines Oncology Devices Market
23.1. Philippines Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Hong Kong Oncology Devices Market
24.1. Hong Kong Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. New Zealand Oncology Devices Market
25.1. New Zealand Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Taiwan Oncology Devices Market
26.1. Taiwan Oncology Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Taiwan Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. South East Asia Oncology Devices Market
27.1. South East Asia Oncology Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
27.2. South East Asia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. Western Europe Oncology Devices Market
28.1. Western Europe Oncology Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. Western Europe Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. UK Oncology Devices Market
29.1. UK Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Germany Oncology Devices Market
30.1. Germany Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. France Oncology Devices Market
31.1. France Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Italy Oncology Devices Market
32.1. Italy Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Spain Oncology Devices Market
33.1. Spain Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Austria Oncology Devices Market
34.1. Austria Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Belgium Oncology Devices Market
35.1. Belgium Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
36. Denmark Oncology Devices Market
36.1. Denmark Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
37. Finland Oncology Devices Market
37.1. Finland Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
38. Ireland Oncology Devices Market
38.1. Ireland Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
39. Netherlands Oncology Devices Market
39.1. Netherlands Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
40. Norway Oncology Devices Market
40.1. Norway Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
41. Portugal Oncology Devices Market
41.1. Portugal Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
42. Sweden Oncology Devices Market
42.1. Sweden Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
42. Switzerland Oncology Devices Market
42.1. Switzerland Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
43. Eastern Europe Oncology Devices Market
43.1. Eastern Europe Oncology Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
43.2. Eastern Europe Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
44. Russia Oncology Devices Market
44.1. Russia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
45. Czech Republic Oncology Devices Market
45.1. Czech Republic Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
46. Poland Oncology Devices Market
46.1. Poland Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
47. Romania Oncology Devices Market
47.1. Romania Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
48. Ukraine Oncology Devices Market
48.1. Ukraine Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
49. North America Oncology Devices Market
49.1. North America Oncology Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
49.2. North America Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
50. USA Oncology Devices Market
50.1. USA Oncology Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
50.2. USA Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
51. Canada Oncology Devices Market
51.1. Canada Oncology Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
51.2. Canada Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
52. Mexico Oncology Devices Market
52.1. Mexico Oncology Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
52.2. Mexico Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
53. South America Oncology Devices Market
53.1. South America Oncology Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
53.2. South America Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
54. Brazil Oncology Devices Market
54.1. Brazil Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
55. Chile Oncology Devices Market
55.1. Chile Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
56. Argentina Oncology Devices Market
56.1. Argentina Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
57. Colombia Oncology Devices Market
57.1. Colombia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
58. Peru Oncology Devices Market
58.1. Peru Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
59. Middle East Oncology Devices Market
59.1. Middle East Oncology Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
59.2. Middle East Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
60. Saudi Arabia Oncology Devices Market
60.1. Saudi Arabia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
61. Israel Oncology Devices Market
61.1. Israel Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
62. Iran Oncology Devices Market
62.1. Iran Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
63. Turkey Oncology Devices Market
63.1. Turkey Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
64. United Arab Emirates Oncology Devices Market
64.1. United Arab Emirates Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
65. Africa Oncology Devices Market
65.1. Africa Oncology Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
65.2. Africa Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
66. Egypt Oncology Devices Market
66.1. Egypt Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
67. Nigeria Oncology Devices Market
67.1. Nigeria Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
68. South Africa Oncology Devices Market
68.1. South Africa Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
69. Oncology Devices Market Regulatory and Investment Landscape
70. Oncology Devices Market Competitive Landscape And Company Profiles
70.1. Oncology Devices Market Competitive Landscape And Market Share 2024
70.1.1. Top 10 Companies (Ranked by revenue/share)
70.2. Oncology Devices Market - Company Scoring Matrix
70.2.1. Market Revenues
70.2.2. Product Innovation Score
70.2.3. Brand Recognition
70.3. Oncology Devices Market Company Profiles
70.3.1. Eckert & Ziegler BEBIG GmbH Overview, Products and Services, Strategy and Financial Analysis
70.3.2. Oncura Inc. Overview, Products and Services, Strategy and Financial Analysis
70.3.3. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
70.3.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
70.3.5. Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis
71. Oncology Devices Market Other Major And Innovative Companies
Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer
72. Global Oncology Devices Market Competitive Benchmarking And Dashboard
73. Key Mergers And Acquisitions In The Oncology Devices Market
74. Oncology Devices Market High Potential Countries, Segments and Strategies
74.1 Oncology Devices Market In 2030 - Countries Offering Most New Opportunities
74.2 Oncology Devices Market In 2030 - Segments Offering Most New Opportunities
74.3 Oncology Devices Market In 2030 - Growth Strategies
